Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether the addition of oral flecainide to standard
therapy will reduce ventricular ectopy on exercise test compared to placebo plus standard
therapy in patients with Catecholaminergic Polymorphic Ventricular Tachycardia.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center